Qiagen N.V. (NYSE:QGEN) Stock Has Consensus Target Price of $43.51
MarketBeat
Qiagen N.V. (NYSE:QGEN) has received an average "Hold" rating from 14 brokerages, with a consensus 12-month price target of $43.51, slightly below its current trading price of $44.15. The company recently exceeded quarterly earnings and revenue expectations, reporting $0.62 per share on $535.04 million in revenue. Institutional investors hold approximately 70% of Qiagen's stock.
Read the full story
This is a short summary. The complete article is published by MarketBeat.
Headline and summary aggregated from public news feeds. For information only — not financial advice.